Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.69 |
| ▸ | MEN1 | O00255 | 2/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.69 |
| ▸ | EP300 | Q09472 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.57 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.57 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.53 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.53 |
| ▸ | GFER | P55789 | 1/20 | 0.51 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10619794 | 0.87 | GAA (0.82) | GAAALOX15HSD17B10ALDH1A1MEN1 | |
| SCHEMBL13510376 | 0.86 | EP300 (0.80) | GAAALOX15HSD17B10ALDH1A1MEN1 | |
| SCHEMBL1151730 | 0.83 | ERBB2 (0.59) | GAAALOX15HSD17B10ALDH1A1MEN1 | |
| SCHEMBL6806783 | 0.81 | GAA (0.72) | GAAALOX15HSD17B10ALDH1A1MEN1 | |
| SCHEMBL6803322 | 0.81 | GAA (0.60) | GAAALOX15HSD17B10ALDH1A1MEN1 | |
| SCHEMBL5694590 | 0.79 | ERBB2 (0.59) | GAAALOX15HSD17B10ALDH1A1MEN1 | |
| SCHEMBL1151729 | 0.79 | GAA (0.80) | GAAALOX15HSD17B10ALDH1A1MEN1 | |
| SCHEMBL13510382 | 0.78 | EP300 (0.80) | GAAALOX15HSD17B10ALDH1A1MEN1 | |
| SCHEMBL11785794 | 0.78 | GAA (0.56) | GAAALOX15HSD17B10ALDH1A1MEN1 | |
| SCHEMBL7573482 | 0.78 | ERBB2 (0.60) | GAAALOX15HSD17B10ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6380146-B1 | FOR BLEACHING STAINS ON FABRICS DURING WASHING, WITHOUT PROVOKING DYE DAMAGE | UNILEVER HOME & PERSONAL CARE USA A DIVISION OF CONOPCO, INC. | 2002-04-30 | — | — | US | claimed |
| EP-1187899-A1 | METHOD AND COMPOSITION FOR ENHANCING THE ACTIVITY OF AN ENZYME | UNILEVER N.V. (NL) | 2002-03-20 | — | — | EP | claimed |
| WO-2001000768-A1 | BLEACHING DETERGENT COMPOSITIONS | UNILEVER N.V. (NL) | 2001-01-04 | — | — | WO | claimed |
| WO-2001000769-A1 | METHOD AND COMPOSITION FOR ENHANCING THE ACTIVITY OF AN ENZYME | UNILEVER N.V. (NL) | 2001-01-04 | — | — | WO | claimed |
| US-20120100609-A1 | N-LINKED GLYCAN BIOSYNTHESIS MODULATORS | BIOMARIN PHARMACEUTICAL INC. | 2012-04-26 | — | — | US | disclosed |
| US-6380146-B1 | FOR BLEACHING STAINS ON FABRICS DURING WASHING, WITHOUT PROVOKING DYE DAMAGE | UNILEVER HOME & PERSONAL CARE USA A DIVISION OF CONOPCO, INC. | 2002-04-30 | — | — | US | disclosed |
| EP-1187899-A1 | METHOD AND COMPOSITION FOR ENHANCING THE ACTIVITY OF AN ENZYME | UNILEVER N.V. (NL) | 2002-03-20 | — | — | EP | disclosed |
| US-6323014-B1 | USED FOR REMOVING COLOURED STAINS FROM FABRICS BY WASHING | UNILEVER HOME & PERSONAL CARE DIVISION OF CONOPCO, INC. | 2001-11-27 | — | — | US | disclosed |
| WO-2001000768-A1 | BLEACHING DETERGENT COMPOSITIONS | UNILEVER N.V. (NL) | 2001-01-04 | — | — | WO | disclosed |
| WO-2001000769-A1 | METHOD AND COMPOSITION FOR ENHANCING THE ACTIVITY OF AN ENZYME | UNILEVER N.V. (NL) | 2001-01-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120100609-A1 | N-LINKED GLYCAN BIOSYNTHESIS MODULATORS | ENGASE, GALNT1, GALNT13 | GAA 98/4885ALOX15 3238/4885HSD17B10 783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.